Abstract
OBJECTIVES—To investigate the incidence of hyperreflexia in patients with Guillain-Barré syndrome (GBS), and its relation with electrodiagnosis of acute motor axonal neuropathy (AMAN), antiganglioside GM1 antibody, and Campylobacter jejuni infection. It was reported that patients with AMAN in northern China often had hyperreflexia in the recovery phase. METHODS—In 54 consecutive Japanese patients with GBS, sequential findings of tendon reflexes were reviewed. By electrodiagnostic criteria, patients were classified as having AMAN or acute inflammatory demyelinating polyneuropathy (AIDP). Anti-GM1 and anti-C jejuni antibodies were measured by enzyme linked immunosorbent assays. RESULTS—Seven (13%) patients developed hyperreflexia with the spread of the myotatic reflex to other segments in the early recovery phase, one of whom already had hyperreflexia in the acute progressive phase. Of the seven patients, six had AMAN and all seven had anti-GM1 antibodies, whereas only two had anti-C jejuni antibodies. Hyperreflexia was more often found in patients with AMAN than AIDP (6/23 v 1/18, p=0.002), and in patients with anti-GM1 antibodies than without them (7/26 v 0/28, p=0.01). Hyperreflexic patients had milder peak disabilities than patients without hyperreflexia (p=0.03). Increased motor neuron excitability in the hyperreflexic patients was supported by increased soleus H-reflex amplitudes and the appearance of H-reflexes in the small hand or foot muscles. CONCLUSIONS—Hyperreflexia often occurs in patients with GBS especially with AMAN, anti-GM1 antibodies, and milder disease. Increased motor neuron excitability further characterises the subgroup of patients with GBS with AMAN and anti-GM1 antibodies.
Full Text
The Full Text of this article is available as a PDF (128.5 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Asbury A. K., Cornblath D. R. Assessment of current diagnostic criteria for Guillain-Barré syndrome. Ann Neurol. 1990;27 (Suppl):S21–S24. doi: 10.1002/ana.410270707. [DOI] [PubMed] [Google Scholar]
- Brown W. F., Snow R. Patterns and severity of conduction abnormalities in Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry. 1991 Sep;54(9):768–774. doi: 10.1136/jnnp.54.9.768. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fisher M. A. AAEM Minimonograph #13: H reflexes and F waves: physiology and clinical indications. Muscle Nerve. 1992 Nov;15(11):1223–1233. doi: 10.1002/mus.880151102. [DOI] [PubMed] [Google Scholar]
- Ho T. W., Mishu B., Li C. Y., Gao C. Y., Cornblath D. R., Griffin J. W., Asbury A. K., Blaser M. J., McKhann G. M. Guillain-Barré syndrome in northern China. Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies. Brain. 1995 Jun;118(Pt 3):597–605. doi: 10.1093/brain/118.3.597. [DOI] [PubMed] [Google Scholar]
- Jackson C. E., Barohn R. J., Mendell J. R. Acute paralytic syndrome in three American men. Comparison with Chinese cases. Arch Neurol. 1993 Jul;50(7):732–735. doi: 10.1001/archneur.1993.00540070050014. [DOI] [PubMed] [Google Scholar]
- Jacobs B. C., van Doorn P. A., Schmitz P. I., Tio-Gillen A. P., Herbrink P., Visser L. H., Hooijkass H., van der Meché F. G. Campylobacter jejuni infections and anti-GM1 antibodies in Guillain-Barré syndrome. Ann Neurol. 1996 Aug;40(2):181–187. doi: 10.1002/ana.410400209. [DOI] [PubMed] [Google Scholar]
- Kinsella L. J., Lange D. J., Trojaborg W., Sadiq S. A., Younger D. S., Latov N. Clinical and electrophysiologic correlates of elevated anti-GM1 antibody titers. Neurology. 1994 Jul;44(7):1278–1282. doi: 10.1212/wnl.44.7.1278. [DOI] [PubMed] [Google Scholar]
- Koga M., Yuki N., Takahashi M., Saito K., Hirata K. Close association of IgA anti-ganglioside antibodies with antecedent Campylobacter jejuni infection in Guillain-Barré and Fisher's syndromes. J Neuroimmunol. 1998 Jan;81(1-2):138–143. doi: 10.1016/s0165-5728(97)00168-9. [DOI] [PubMed] [Google Scholar]
- Kornberg A. J., Pestronk A., Bieser K., Ho T. W., McKhann G. M., Wu H. S., Jiang Z. The clinical correlates of high-titer IgG anti-GM1 antibodies. Ann Neurol. 1994 Feb;35(2):234–237. doi: 10.1002/ana.410350217. [DOI] [PubMed] [Google Scholar]
- Kuwabara S., Yuki N., Koga M., Hattori T., Matsuura D., Miyake M., Noda M. IgG anti-GM1 antibody is associated with reversible conduction failure and axonal degeneration in Guillain-Barré syndrome. Ann Neurol. 1998 Aug;44(2):202–208. doi: 10.1002/ana.410440210. [DOI] [PubMed] [Google Scholar]
- McKhann G. M., Cornblath D. R., Griffin J. W., Ho T. W., Li C. Y., Jiang Z., Wu H. S., Zhaori G., Liu Y., Jou L. P. Acute motor axonal neuropathy: a frequent cause of acute flaccid paralysis in China. Ann Neurol. 1993 Apr;33(4):333–342. doi: 10.1002/ana.410330402. [DOI] [PubMed] [Google Scholar]
- McKhann G. M., Cornblath D. R., Ho T., Li C. Y., Bai A. Y., Wu H. S., Yei Q. F., Zhang W. C., Zhaori Z., Jiang Z. Clinical and electrophysiological aspects of acute paralytic disease of children and young adults in northern China. Lancet. 1991 Sep 7;338(8767):593–597. doi: 10.1016/0140-6736(91)90606-p. [DOI] [PubMed] [Google Scholar]
- Olsson Y. Topographical differences in the vascular permeability of the peripheral nervous system. Acta Neuropathol. 1968 Jan 2;10(1):26–33. doi: 10.1007/BF00690507. [DOI] [PubMed] [Google Scholar]
- Pestronk A., Cornblath D. R., Ilyas A. A., Baba H., Quarles R. H., Griffin J. W., Alderson K., Adams R. N. A treatable multifocal motor neuropathy with antibodies to GM1 ganglioside. Ann Neurol. 1988 Jul;24(1):73–78. doi: 10.1002/ana.410240113. [DOI] [PubMed] [Google Scholar]
- Pryor W. M., Freiman J. S., Gillies M. A., Tuck R. R. Guillain-Barré syndrome associated with Campylobacter infection. Aust N Z J Med. 1984 Oct;14(5):687–688. doi: 10.1111/j.1445-5994.1984.tb05033.x. [DOI] [PubMed] [Google Scholar]
- Rees J. H., Gregson N. A., Hughes R. A. Anti-ganglioside GM1 antibodies in Guillain-Barré syndrome and their relationship to Campylobacter jejuni infection. Ann Neurol. 1995 Nov;38(5):809–816. doi: 10.1002/ana.410380516. [DOI] [PubMed] [Google Scholar]
- Schwerer B., Lassmann H., Kitz K., Bernheimer H. Ganglioside GM1, a molecular target for immunological and toxic attacks: similarity of neuropathological lesions induced by ganglioside-antiserum and cholera toxin. Acta Neuropathol. 1986;72(1):55–61. doi: 10.1007/BF00687947. [DOI] [PubMed] [Google Scholar]
- Visser L. H., Van der Meché F. G., Van Doorn P. A., Meulstee J., Jacobs B. C., Oomes P. G., Kleyweg R. P., Meulstee J. Guillain-Barré syndrome without sensory loss (acute motor neuropathy). A subgroup with specific clinical, electrodiagnostic and laboratory features. Dutch Guillain-Barré Study Group. Brain. 1995 Aug;118(Pt 4):841–847. doi: 10.1093/brain/118.4.841. [DOI] [PubMed] [Google Scholar]
- Vriesendorp F. J., Mishu B., Blaser M. J., Koski C. L. Serum antibodies to GM1, GD1b, peripheral nerve myelin, and Campylobacter jejuni in patients with Guillain-Barré syndrome and controls: correlation and prognosis. Ann Neurol. 1993 Aug;34(2):130–135. doi: 10.1002/ana.410340206. [DOI] [PubMed] [Google Scholar]
- Yuki N. Acute paresis of extraocular muscles associated with IgG anti-GQ1b antibody. Ann Neurol. 1996 May;39(5):668–672. doi: 10.1002/ana.410390517. [DOI] [PubMed] [Google Scholar]
- Yuki N., Hirata K. Preserved tendon reflexes in Campylobacter neuropathy. Ann Neurol. 1998 Apr;43(4):546–547. doi: 10.1002/ana.410430424. [DOI] [PubMed] [Google Scholar]
- van der Meché F. G., Meulstee J., Vermeulen M., Kievit A. Patterns of conduction failure in the Guillain-Barré syndrome. Brain. 1988 Apr;111(Pt 2):405–416. doi: 10.1093/brain/111.2.405. [DOI] [PubMed] [Google Scholar]